{"title":"女性动脉高血压合并代谢综合征的情感性障碍","authors":"Roman A. Yaskevich, Olga L. Moskalenko","doi":"10.12731/2658-6649-2023-15-2-284-302","DOIUrl":null,"url":null,"abstract":"Purpose. To study the features of affective disorders in women with comorbid chronic ischemic heart disease with metabolic syndrome.
 Materials and methods. The study was performed with the participation of 160 female patients diagnosed with chronic ischemic heart disease. Metabolic syndrome verification was carried out using the clinical recommendations of the All-Russian Scientific Society of Cardiology (2009). Identification of the presence of anxiety-depressive states and assessment of their severity was carried out using The Hospital Anxiety and Depression scale.
 Results. The study showed that 50,9% of the surveyed women with a combination of chronic ischemic heart disease and metabolic syndrome had elevated levels of anxiety. Anxiety disorders of a subclinically pronounced nature were found in 31,1% of the surveyed in this group, and clinically pronounced in 19,6%. Elevated levels of depression were detected in 35,7% of the examined patients with metabolic syndrome. Depressive disorders, which were subclinically pronounced, were found in 18,7% of the examined in this group, and clinically pronounced in 17,0%. The most frequent cluster of metabolic syndrome in the studied group of women, both with an increased level of anxiety and with an increased level of depression, was a three-component cluster of metabolic syndrome – 47,4% and 42,5%.
 Conclusion. Among patients with chronic ischemic heart disease with a comorbid course with metabolic syndrome, the number of people with clinically pronounced anxiety and depression was generally higher in comparison with people without metabolic syndrome. At the same time, the number of patients with metabolic syndrome with clinically pronounced depression was twice as high – 17,0% and 8.0%. More often in both groups there was a cluster of metabolic syndrome, including a combination of hypertension with abdominal obesity and lipid disorders.","PeriodicalId":21854,"journal":{"name":"Siberian Journal of Life Sciences and Agriculture","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME\",\"authors\":\"Roman A. Yaskevich, Olga L. Moskalenko\",\"doi\":\"10.12731/2658-6649-2023-15-2-284-302\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose. To study the features of affective disorders in women with comorbid chronic ischemic heart disease with metabolic syndrome.
 Materials and methods. The study was performed with the participation of 160 female patients diagnosed with chronic ischemic heart disease. Metabolic syndrome verification was carried out using the clinical recommendations of the All-Russian Scientific Society of Cardiology (2009). Identification of the presence of anxiety-depressive states and assessment of their severity was carried out using The Hospital Anxiety and Depression scale.
 Results. The study showed that 50,9% of the surveyed women with a combination of chronic ischemic heart disease and metabolic syndrome had elevated levels of anxiety. Anxiety disorders of a subclinically pronounced nature were found in 31,1% of the surveyed in this group, and clinically pronounced in 19,6%. Elevated levels of depression were detected in 35,7% of the examined patients with metabolic syndrome. Depressive disorders, which were subclinically pronounced, were found in 18,7% of the examined in this group, and clinically pronounced in 17,0%. The most frequent cluster of metabolic syndrome in the studied group of women, both with an increased level of anxiety and with an increased level of depression, was a three-component cluster of metabolic syndrome – 47,4% and 42,5%.
 Conclusion. Among patients with chronic ischemic heart disease with a comorbid course with metabolic syndrome, the number of people with clinically pronounced anxiety and depression was generally higher in comparison with people without metabolic syndrome. At the same time, the number of patients with metabolic syndrome with clinically pronounced depression was twice as high – 17,0% and 8.0%. More often in both groups there was a cluster of metabolic syndrome, including a combination of hypertension with abdominal obesity and lipid disorders.\",\"PeriodicalId\":21854,\"journal\":{\"name\":\"Siberian Journal of Life Sciences and Agriculture\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Siberian Journal of Life Sciences and Agriculture\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12731/2658-6649-2023-15-2-284-302\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Agricultural and Biological Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Siberian Journal of Life Sciences and Agriculture","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12731/2658-6649-2023-15-2-284-302","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
引用次数: 0
摘要
目的。探讨女性慢性缺血性心脏病伴代谢综合征患者情感性障碍的特点。
材料和方法。这项研究是在160名诊断为慢性缺血性心脏病的女性患者的参与下进行的。代谢综合征验证采用全俄科学心脏病学会(2009)的临床建议进行。使用医院焦虑抑郁量表(the Hospital Anxiety and Depression scale)识别焦虑抑郁状态的存在并评估其严重程度。
结果。研究表明,50.9%患有慢性缺血性心脏病和代谢综合征的受访女性焦虑水平升高。亚临床表现的焦虑障碍在31.1%的被调查者中被发现,在19.6%的被调查者中被发现有临床表现。在接受检查的代谢综合征患者中,35.7%的人发现抑郁水平升高。在这组被检查的患者中,有18.7%的人出现了亚临床表现的抑郁症,有17.0%的人出现了临床表现。在研究组中,最常见的代谢综合征群,既有焦虑水平的增加,也有抑郁水平的增加,是代谢综合征的三组分群- 47.4%和42.5%。结论。在伴有代谢综合征的慢性缺血性心脏病患者中,与没有代谢综合征的患者相比,临床表现出焦虑和抑郁的人数普遍较高。与此同时,伴有临床表现抑郁的代谢综合征患者数量为17.0%和8.0%,是前者的两倍。两组患者更常出现代谢综合征,包括高血压合并腹部肥胖和脂质紊乱。
AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
Purpose. To study the features of affective disorders in women with comorbid chronic ischemic heart disease with metabolic syndrome.
Materials and methods. The study was performed with the participation of 160 female patients diagnosed with chronic ischemic heart disease. Metabolic syndrome verification was carried out using the clinical recommendations of the All-Russian Scientific Society of Cardiology (2009). Identification of the presence of anxiety-depressive states and assessment of their severity was carried out using The Hospital Anxiety and Depression scale.
Results. The study showed that 50,9% of the surveyed women with a combination of chronic ischemic heart disease and metabolic syndrome had elevated levels of anxiety. Anxiety disorders of a subclinically pronounced nature were found in 31,1% of the surveyed in this group, and clinically pronounced in 19,6%. Elevated levels of depression were detected in 35,7% of the examined patients with metabolic syndrome. Depressive disorders, which were subclinically pronounced, were found in 18,7% of the examined in this group, and clinically pronounced in 17,0%. The most frequent cluster of metabolic syndrome in the studied group of women, both with an increased level of anxiety and with an increased level of depression, was a three-component cluster of metabolic syndrome – 47,4% and 42,5%.
Conclusion. Among patients with chronic ischemic heart disease with a comorbid course with metabolic syndrome, the number of people with clinically pronounced anxiety and depression was generally higher in comparison with people without metabolic syndrome. At the same time, the number of patients with metabolic syndrome with clinically pronounced depression was twice as high – 17,0% and 8.0%. More often in both groups there was a cluster of metabolic syndrome, including a combination of hypertension with abdominal obesity and lipid disorders.